Elanco Animal Health Stock Performance
| ELAN Stock | USD 10.53 0.05 0.47% |
The firm shows a Beta (market volatility) of 0.92, which means possible diversification benefits within a given portfolio. Elanco Animal returns are very sensitive to returns on the market. As the market goes up or down, Elanco Animal is expected to follow. At this point, Elanco Animal Health has a negative expected return of -0.18%. Please make sure to confirm Elanco Animal's standard deviation, kurtosis, period momentum indicator, as well as the relationship between the maximum drawdown and day median price , to decide if Elanco Animal Health performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Elanco Animal Health has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors. ...more
Actual Historical Performance (%)
One Day Return (0.47) | Five Day Return (2.68) | Year To Date Return (12.61) | Ten Year Return (70.75) | All Time Return (70.75) |
1 | Acquisition by Rajeev Modi of 114 shares of Elanco Animal subject to Rule 16b-3 | 12/27/2024 |
2 | Acquisition by Lawrence Kurzius of 4954 shares of Elanco Animal subject to Rule 16b-3 | 12/31/2024 |
3 | Disposition of 351 shares by Mcardle Grace of Elanco Animal at 11.98 subject to Rule 16b-3 | 01/03/2025 |
4 | Acquisition by Jeffrey Simmons of 229 shares of Elanco Animal subject to Rule 16b-3 | 01/28/2025 |
5 | FMR LLCs Strategic Acquisition of Elanco Animal Health Inc Shares | 02/12/2025 |
6 | Disposition of 195840 shares by Jeffrey Simmons of Elanco Animal at 11.24 subject to Rule 16b-3 | 02/21/2025 |
7 | Elanco Enters Agreement With Medgene To Commercialize Highly Pathogenic Avian Influenza Vaccine ... | 02/25/2025 |
8 | How Elanco Animal Health Responded to Market Pressure Following Q4 Results | 02/26/2025 |
9 | Phocas Financial Corp. Has 418,000 Holdings in Elanco Animal Health Incorporated | 02/27/2025 |
10 | Disposition of 7162 shares by David Kinard of Elanco Animal at 11.17 subject to Rule 16b-3 | 02/28/2025 |
11 | Acquisition by Mcardle Grace of 59138 shares of Elanco Animal at 11.31 subject to Rule 16b-3 | 03/03/2025 |
12 | Acquisition by Todd Young of 2000 shares of Elanco Animal subject to Rule 16b-3 | 03/04/2025 |
13 | Acquisition by R Hoover of 25000 shares of Elanco Animal at 10.9023 subject to Rule 16b-3 | 03/05/2025 |
14 | FMR LLCs Strategic Acquisition of Elanco Animal Health Shares | 03/07/2025 |
15 | Acquisition by Lawrence Kurzius of 10000 shares of Elanco Animal at 10.2 subject to Rule 16b-3 | 03/11/2025 |
16 | Why Elanco Animal Health Incorporated Went Down on Tuesday | 03/12/2025 |
17 | Are Options Traders Betting on a Big Move in Elanco Animal Health Stock | 03/13/2025 |
18 | Elanco Announces Changes to Board of Directors Signs Research Agreement to Explore Novel ... | 03/17/2025 |
19 | Q4 Earnings Roundup Elanco And The Rest Of The Pharmaceuticals Segment | 03/18/2025 |
20 | How Is Elanco Animal Health Managing Its Growth Strategy | 03/19/2025 |
21 | Heres Why Elanco Animal Health Incorporated Declined in Q4 | 03/21/2025 |
| Begin Period Cash Flow | 352 M |
Elanco |
Elanco Animal Relative Risk vs. Return Landscape
If you would invest 1,188 in Elanco Animal Health on December 24, 2024 and sell it today you would lose (135.00) from holding Elanco Animal Health or give up 11.36% of portfolio value over 90 days. Elanco Animal Health is currently does not generate positive expected returns and assumes 2.1164% risk (volatility on return distribution) over the 90 days horizon. In different words, 18% of stocks are less volatile than Elanco, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Elanco Animal Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Elanco Animal's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Elanco Animal Health, and traders can use it to determine the average amount a Elanco Animal's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0844
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ELAN |
Estimated Market Risk
| 2.12 actual daily | 18 82% of assets are more volatile |
Expected Return
| -0.18 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Elanco Animal is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Elanco Animal by adding Elanco Animal to a well-diversified portfolio.
Elanco Animal Fundamentals Growth
Elanco Stock prices reflect investors' perceptions of the future prospects and financial health of Elanco Animal, and Elanco Animal fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Elanco Stock performance.
| Return On Equity | 0.0549 | ||||
| Return On Asset | 0.0119 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 9.06 B | ||||
| Shares Outstanding | 494.61 M | ||||
| Price To Earning | 241.75 X | ||||
| Price To Book | 0.85 X | ||||
| Price To Sales | 1.17 X | ||||
| Revenue | 4.44 B | ||||
| Gross Profit | 2.44 B | ||||
| EBITDA | 1.39 B | ||||
| Net Income | 338 M | ||||
| Cash And Equivalents | 463 M | ||||
| Cash Per Share | 0.98 X | ||||
| Total Debt | 4.32 B | ||||
| Debt To Equity | 0.87 % | ||||
| Current Ratio | 1.96 X | ||||
| Book Value Per Share | 12.33 X | ||||
| Cash Flow From Operations | 541 M | ||||
| Earnings Per Share | 0.68 X | ||||
| Market Capitalization | 5.21 B | ||||
| Total Asset | 12.61 B | ||||
| Retained Earnings | (1.95 B) | ||||
| Working Capital | 1.9 B | ||||
| Current Asset | 2.45 B | ||||
| Current Liabilities | 805.47 M | ||||
About Elanco Animal Performance
By examining Elanco Animal's fundamental ratios, stakeholders can obtain critical insights into Elanco Animal's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Elanco Animal is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 227.08 | 207.69 | |
| Return On Tangible Assets | 0.07 | 0.08 | |
| Return On Capital Employed | 0.02 | 0.03 | |
| Return On Assets | 0.03 | 0.03 | |
| Return On Equity | 0.06 | 0.06 |
Things to note about Elanco Animal Health performance evaluation
Checking the ongoing alerts about Elanco Animal for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Elanco Animal Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Elanco Animal Health generated a negative expected return over the last 90 days | |
| Elanco Animal Health is unlikely to experience financial distress in the next 2 years | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from insidermonkey.com: Heres Why Elanco Animal Health Incorporated Declined in Q4 |
- Analyzing Elanco Animal's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Elanco Animal's stock is overvalued or undervalued compared to its peers.
- Examining Elanco Animal's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Elanco Animal's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Elanco Animal's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Elanco Animal's stock. These opinions can provide insight into Elanco Animal's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elanco Animal. If investors know Elanco will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elanco Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.71) | Earnings Share 0.68 | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets |
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elanco Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elanco Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elanco Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.